News tagged with patent protection

Related topics:

Lilly, Boehringer collaborate on diabetes drugs

(AP) -- Eli Lilly will pay Boehringer Ingelheim $387.4 million and collaborate with the German drugmaker to develop diabetes drugs with the U.S. pharmaceutical company facing the expiration of some of its key patents.

dateJan 11, 2011 in Medications
shares0 comments 1